Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange
February 14, 2017 16:01 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology, announced today that it will file a petition...
First Cancer Patient Treated In Phase I/II Trial of ApoGraft™
February 08, 2017 07:05 ET | Cellect Biotechnology Ltd.
Management expects additional positive upcoming results from its trial in healthy volunteers TEL AVIV, Israel, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd....
Dr. Yaron Pereg Appointed as New Chief Development Officer
January 30, 2017 16:15 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Jan. 30, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology, today announces that it has appointed Yaron...
Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications
January 12, 2017 08:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology, announces today that it has received a...
Major Shareholder Buying Shares
January 09, 2017 08:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of stem cells isolation technology announces today that it has received notice,...
Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer
January 03, 2017 08:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells,...
Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results
November 28, 2016 08:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem cells,...
Cellect signs agreement with the Hadassah Technological Transfer Company – Hadasit
November 23, 2016 10:44 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Cellect biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP) (hereinafter the “Company”) announces it has signed an agreement with Hadasit, the...
Cellect Receives Israeli Ministry of Health Approval to Initiate Phase I/II Clinical Trial in Leukemia Patients
September 13, 2016 08:00 ET | Cellect Biotechnology Ltd.
Company’s innovative cell selection product may dramatically reduce bone marrow transplantation risks Patient enrollment expected to begin in the next few weeks TEL AVIV, Israel, Sept. 13, 2016 ...
Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter 2016 Financial Results
September 01, 2016 08:00 ET | Cellect Biotechnology Ltd.
TEL AVIV, Israel, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ:APOP) (TASE:APOP), a developer of innovative technology which enables the functional selection of stem...